In a recent report published in the Journal of Experimental Medicine, researchers describe a particle that they discovered in the bloodstream of sepsis patients, which they believe could lead to new insights into the immune system.
Under detection and underreporting are problematic for a variety of reasons. They make it more difficult to understand the true spread of the virus, which impacts everything from resource planning in healthcare systems to public policies designed to reduce infection spread.
As infectious diseases evolve, the medical community has been working to meet the challenge by updating and improving the tools we use to combat infections. Right now, biopharmaceutical research companies have 421 medicines and vaccines in development to treat or prevent fungal, bacterial, and viral infections.